BILL 102: Drug Transparency Act - Apr. 25, 06 PDF Print E-mail
Monday, 24 April 2006 19:00
LEGISLATIVE ASSEMBLY OF ONTARIO

Tuesday 25 April 2006

TRANSPARENT DRUG SYSTEM
FOR PATIENTS ACT, 2006

Ms. Lisa MacLeod (Nepean-Carleton): It's my pleasure to address this Bill 102 today. There's no question that the Conservative Party believes that Ontarians need to be sure that they can get the right health care at the right time. This bill, however, we believe introduces a significant degree of uncertainty with respect to the research and development sector of our economy, as well as small, independent pharmacies. This puts some 30,000 high-paying jobs at risk in Ontario.

As one of the pharmacists in my community, the Nepean Medical Pharmacy, run by Danny Souaid, tells me, he's got concerns that this legislation can seriously harm retail pharmacies, especially independent pharmacies in Ontario. He tells me that he doesn't believe the present government understands how important independent pharmacies are to the economy, especially to Ontario's health. He spoke to the Ontario Pharmacists' Association to let them know that pharmacy owners have not seen a reasonable dispensing fee increase in over a decade. He told me that there has been a decrease of the markup from 10% to 8% on his products, and he's certainly hoping that we're making it clear to the ministry, through this Legislature today, that many drugs can't be purchased directly from the manufacturer. He told me today that Quebec only allows for a standard of 30-day supply on drugs. All studies have shown this would decrease wastage and misuse. If the government is seriously considering cost-saving measures, then my constituent believes that this should now be the standard in Ontario as well.

He has other concerns. He believes that Bill 102 can hurt pharmacies tremendously. He tells me that he will have to lay off employees at the end of the summer. Collectively, throughout the province, he believes many jobs will be lost and wages lowered to the point where the profession will no longer be attractive to anyone considering a career in pharmaceuticals. I would hope that these issues could be addressed through this Legislature by the other side.

DEBATE RESUMES

Ms. MacLeod: The minister claims that patients will not notice the changes to the system. Having said that, however, Danny Souaid, from the Nepean Medical Pharmacy in my constituency, has severe concerns about staying in business. I think patients will notice this. I think they'll notice throughout northern and rural Ontario -- and the riding I represent is rural -- that when the sole health care provider in their community, the pharmacist, isn't able to see them because the government drove the pharmacy out of business, it doesn't necessarily help the health care system.

This is not just in my riding of Nepean-Carleton. Danielle Edgar, a pharmacist with Lambton Pharmacy in Petrolia, according to the Sarnia Observer, basically says, "The average person getting a prescription filled isn't likely to notice much of a change." In the same article in the Sarnia Observer, there's also a dilemma that Darren Nesbit is talking about. He's from Sarnia, and he has been fighting the province to approve an expensive drug treatment for a rare genetic disorder. Darren is telling his newspaper that he feels more loyal to the drug company than to his own government. He thinks that's sad, because he's concerned that if there's a lower profit margin on these drugs, it will force companies and manufacturers to stop providing this life-saving treatment, and they're going to leave the province. Cut off his drug treatments and he could die, he's saying. This is not inflammatory language. This is exactly what this patient is saying.

I think these issues have to be addressed in this legislation. I encourage the honourable members on the opposite side to look at these concerns that Ontarians, patients, small independent pharmacists are offering by way of newspapers and by way of members on the opposite side of the chamber.